Two new studies published in PNAS suggest gut microbes may play a key role in the neurodegeneration associated with multiple sclerosis. The findings could help researchers identify new therapies to help treat the autoimmune disease, such as dietary changes and drugs based on microbial byproducts.
A new study from Virginia Tech reveals a healthy bacteria found in yogurt could reduce some lupus symptoms. The study expands on earlier work from the researchers, noting a lack of Lactobacillus in both mice and humans with lupus.
A study in Nature Immunology reports on the mechanism that helps to prevent autoimmune diseases from developing following infection. Researchers report a population of immune cells develop during late stages of the immune response to influenza infection.
UCSF researchers reveal a common over the counter antihistamine appears to accelerate neural signaling and restore nervous system functioning for some multiple sclerosis patients.
Using titanate nanowires treated with cerebrolysin, researchers have been able to target delivery to the brain and through the central nervous system. Researchers report the use of nanowires to deliver drugs could be beneficial in the treatment of Alzheimer's, Parkinson's and other neurodegenerative diseases.
Genetic risk factors, age and gut bacteria appear to work in collaboration to trigger multiple sclerosis, a new study reports.
A new study reveals how autophagy in certain immune cells can lead to the immune system attacking the central nervous system. The findings have implications for the treatment of autoimmune diseases, like multiple sclerosis.
Researchers report they have found no increased risk of autoimmune diseases in girls who received the HPV4 vaccine. The study adds to a growing body of evidence for the safety of the vaccine.